With more than 250 scientific citations, Oncomine has become an industry standard for cancer researchers. This is a series that features some of the latest scientific publications and how these scientists used Oncomine in various and novel ways for their research.

03 FEB 2010
Inactivation of clusterin contributes to tumorigenesis in prostate cancer mouse models.
...reported that the loss of clusterin (CLU) expression resulted in prostate epithelial transformation, metastatic spread, and tumorigenesis1. These authors provide a mechanistic model for these events by demonstrating an increase in NFKB expression in CLU knockout mice. To understand the functional role of CLU...

PUBMED

MORE